Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 660

1.

[Plasmocytic pleural effusion disclosing multiple myeloma].

Elloumi M, Frikha M, Masmoudi H, Mseddi S, Ben Ayed M, Bouaziz M, Makni F, Souissi T.

Rev Mal Respir. 2000 Apr;17(2):495-7. French.

PMID:
10859769
2.

[Pleural effusion as a first sign of Ig D lambda multiple myeloma].

Maachi M, Fellahi S, Diop ME, Francois T, Capeau J, Bastard JP.

Ann Med Interne (Paris). 2003 Feb;154(1):70-2. French.

PMID:
12746663
3.

Myelomatous effusion with poor response to chemotherapy.

Kim YM, Lee KK, Oh HS, Park SK, Won JH, Hong DS, Park HS, Park JS, Lee DW.

J Korean Med Sci. 2000 Apr;15(2):243-6.

4.

Cell kinetics and therapy in multiple myeloma: an update of the M83 protocol.

Pileri A, Barbui T, Boccadoro M, Comotti B, Dammacco F, Gallamini A, Marmont F, Neretto G, Petrucci MT, Resegotti L, et al.

Bone Marrow Transplant. 1989 Jan;4 Suppl 1:168-9. No abstract available.

PMID:
2713554
5.

Pleural and pericardial effusion as the first sign of multiple myeloma.

André M, Ponsonnaille J, Kemeny JL, Filaire M, Travade P, Aumaitre O.

Ann Med Interne (Paris). 1999 Sep;150(5):443-5.

PMID:
10544757
6.

[A case of aggressive myeloma with abnormal plasmocytes in pleural effusion and cerebrospinal fluid].

Sekikawa T, Iwase S, Kawano T, Takahara S, Ito K, Yamada J, Yamazaki Y, Yamada H.

Rinsho Ketsueki. 1999 Jan;40(1):22-7. Japanese.

PMID:
10067092
7.

[Pulmonary and pleural manifestations of multiple myeloma].

Schelle M, Schreiber C, Knolle J, Florschütz A, Kachel R, Schreiber J.

Pneumologie. 2006 Dec;60(12):743-8. German.

PMID:
17163315
8.

[Therapeutic plasmapheresis in patients with multiple myeloma].

Mendek-Czajkowska E, Kraj M, Pogłód R, Rostkowska J, Maj S, Sabliński J.

Acta Haematol Pol. 1991;22(1):31-41. Polish.

PMID:
1823964
9.

Myeloma with pleural involvement.

Chen LM, Hwang WS.

Acta Cytol. 1991 May-Jun;35(3):372-3. No abstract available.

PMID:
2042441
10.

Flow cytometric disease monitoring in multiple myeloma: the relationship between normal and neoplastic plasma cells predicts outcome after transplantation.

Rawstron AC, Davies FE, DasGupta R, Ashcroft AJ, Patmore R, Drayson MT, Owen RG, Jack AS, Child JA, Morgan GJ.

Blood. 2002 Nov 1;100(9):3095-100.

11.

Pleural effusion as the first sign of multiple myeloma.

Uskül BT, Türker H, Emre Turan F, Unal Bayraktar O, Melikoğlu A, Tahaoğlu C, Oz B.

Tuberk Toraks. 2008;56(4):439-42.

PMID:
19123081
12.
13.

[Intracytoplasmic crystals and Fanconi syndrome in a patient with IgA kappa myeloma].

Martín Reyes G, García González I, Alférez MJ, Martínez González JM, Frutos MA.

Nefrologia. 2001 Mar-Apr;21(2):213-6. Spanish.

14.

[IgD-lambda type multiple myeloma associated with IgG-kappa type benign monoclonal gammopathy].

Shimada H, Nishinarita S, Kishigami Y, Hayama T, Sawada U, Horie T, Nakamura N, Kato M, Hirano M, Nakamura O, et al.

Nihon Rinsho Meneki Gakkai Kaishi. 1995 Apr;18(2):235-40. Japanese.

PMID:
7553059
15.

Autopsy-documented cure of multiple myeloma 14 years after M2 chemotherapy.

van Hoeven KH, Reed LJ, Factor SM.

Cancer. 1990 Oct 1;66(7):1472-4.

16.

A case of multiple myeloma with nuclear hypersegmentation after MP/VAD/VCAP-IFN therapies with a good prognosis.

Nara M, Suzuki K, Inoue Y, Enomoto H, Saito T, Fujioka S.

Acta Haematol. 1993;90(2):102-3. No abstract available.

PMID:
8285014
17.

IgG1-kappa biclonal gammopathy associated with multiple myeloma suggests a regulatory mechanism.

Pizzolato M, Bragantini G, Bresciani P, Pavlovsky S, Chuba J, Vidal R, Rostagno A, Ghiso J.

Br J Haematol. 1998 Jul;102(2):503-8.

PMID:
9695965
18.

Non-secretory multiple myeloma presenting as primary plasma cell leukaemia.

Sureda A, Pais JR, Pascual J, Pérez Vaquero MA, Hernando JC.

Postgrad Med J. 1992 Jun;68(800):470-2.

19.

[IgG-lambda-type multiple myeloma with plasma-cell pericardial effusion and terminal plasma-cell leukemia].

Klug S, Höltermann F, Fritsch H.

Dtsch Med Wochenschr. 1992 Jun 5;117(23):900-4. German.

PMID:
1597118
20.

Prognostic value of plasma-cell immunophenotype in patients with multiple myeloma.

Sakalová A, Holománová D, Mikulecký M, Mistrík M, Lipsic T, Steruská M.

Neoplasma. 1993;40(6):351-4.

PMID:
8289966

Supplemental Content

Support Center